Find News

Filter articles

Applied Filters

Showing 91 to 100 of 1063 results

Bayer, Meda sue Apotex over nasal spray

US12-10-2021Alex Baldwin

Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.

Teva asks Fed Circ for ‘skinny label’ redo

US12-10-2021Alex Baldwin

Teva Pharmaceuticals has once again petitioned the US Court of Appeals for the Federal Circuit to reconsider its decision in a dispute over generic drug labelling which held that the drugmaker infringed GlaxoSmithKline’s Coreg heart drug.

NJ judge invalidates Sun patent in BromSite suit

US05-10-2021Alex Baldwin

A New Jersey court has invalidated a Sun Pharmaceuticals patent related to its anti-inflammatory eye drops BromSite in an infringement suit against generic drug manufacturer Lupin Pharmaceuticals.

Buyers of Zetia seek class recertification after 4th circ ruling

US28-09-2021Alex Baldwin

Wholesale buyers of MSD’s cholesterol treatment Zetia have asked a Virginia court to recertify their class status and move to trial following a recent fourth circuit ruling that reversed the court’s prior certification.

Pfizer targets Eucrisa generics in five Delaware suits

US28-09-2021Alex Baldwin

Pfizer subsidiary Anacor has filed five lawsuits targeting drug manufacturers looking to manufacture generic versions of its eczema treatment Eucrisa.

Zoetis sues rival over generic pet vomiting treatment

US21-09-2021Alex Baldwin

Veterinary drug maker Dechra’s generic of a drug that treats vomiting in dogs and cats, Cerenia, infringes a patent owned by its competitor Zoetis, a new lawsuit has alleged.

Lawmakers urge USPTO to curb IPR denials under Fintiv

US21-09-2021Alex Baldwin

Several US lawmakers have called upon the US Patent and Trademark Office to curb the increase in inter partes review denials to combat the “soaring cost” of prescription drugs.

Allergan closes the book on Fetzima generics suit

US16-09-2021Alex Baldwin

Allergan has struck a deal with two generic manufacturers to resolve a long-running patent infringement suit over its antidepressant drug Fetzima.

FDA urges USPTO to tackle rising drug costs

US14-09-2021Muireann Bolger

The US Food and Drug Administration has urged the US Patent and Trademark Office (USPTO) to curb drug costs in the wake of President Joe Biden’s plan to promote competition in the pharmaceutical sector.

Pfizer to settle Xeljanz suit with Teva

US09-09-2021Alex Baldwin

Pfizer has asked a Delaware court to drop an infringement lawsuit against Teva Pharmaceuticals over a proposed generic of its rheumatoid arthritis drug Xeljanz.

Showing 91 to 100 of 1063 results